Fairvalue-Calculator Fairvalue-Calculator
EN DE

TCM Biotech International Corp (4169) Fair Value & Analysis

Healthcare · TW · Market cap 11.4B TWD

Price151.00 TWD
Fair Value198.74 TWD
Upside+31.6%
Quality95/100
Evidence: High Range 165.08 TWD – 232.39 TWD

Fair value as of: Jun 24, 2026

✦ Find undervalued quality stocks — 34,000+ analysed Find stocks →

Analysis

TCM Biotech International Corp (4169) currently trades at 151.00 TWD, while our model-based Fair Value estimate is 198.74 TWD — implying the stock looks roughly 31.6% undervalued today. We read business quality at 95/100 (high quality), in the Healthcare sector. Bull case: trading below our estimate, it may offer upside if the fundamentals hold. Bear case: a low price can be a value trap when quality is weak or the data is thin (evidence: high) — always confirm before acting.

About the company

TCM Biotech International Corp., a biotech company, engages in the research and development of drugs for liver diseases. The company offers medical devices, such as therapy for osteoarthritis, intra-articular implant of hyaluronic acid, automated blood cell separator, absorbable adhesion barrier material, prosthetic and orthotic accessory, and pellefeel mask pressure relief pad; and pharmaceuticals, including iron supplement, therapeutic agent for urinary system, expectorant/mucolytic agent, anticancer drug, antihypertensive drug, and antidiabetic. It also provides medical detection platform for breast cancer recurrent risk detection and postoperative detection platform for liver cancer, as well as philips non-invasive positive pressure ventilation and accessories. TCM Biotech International Corp. was founded in 1998 and is headquartered in New Taipei City, Taiwan.

Open the full interactive analysis →

Similar stocks

Vertex Pharmaceuticals Incorporated (VRTX34) -88% Regeneron Pharmaceuticals, Inc (REGN) -14% UCB SA (UCB) -23% argenx SE (ARGNF) -57% Samsung Biologics Co (207940) +9% Alnylam Pharmaceuticals, Inc (ALNY) -62%

Frequently asked questions

Is TCM Biotech International Corp (4169) undervalued?
As of Jun 24, 2026, our model estimates a fair value of 198.74 TWD versus a price of 151.00 TWD — about +32% (undervalued). Model-based estimate, not financial advice.
What is the fair value of 4169?
Our 21-model fair value for TCM Biotech International Corp is 198.74 TWD (as of Jun 24, 2026), built from audited fundamentals. The current price is 151.00 TWD.
What is the quality score of 4169?
TCM Biotech International Corp has a Quality Score of 95/100, measuring profitability, growth and balance-sheet strength from non-valuation factors.

How we calculate Fair Value

Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.

Educational research only · not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.